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In recent years gold nanoparticles (AuNPs) have received considerable attention for various biomedical applications including di-
agnostics and targeted drug delivery. However, more research is still needed to characterize such aspects of their use in clinical 
oncology as permeability, retention and functional effect on tumor cells. Aims: This study was designed to describe the effect 
of non-functionalized AuNPs on LNCaP prostate cancer cells growth. Material and Methods: LNCaP cells were cultured 
in  RPMI-1640 medium containing AuNPs covered by polyvinylpyrrolidone of average size 26.4 nm (10.0 μg/ml). Counts of cells 
were calculated and their morphology was examined. Results: AuNPs conglomerates have been visualized in cultured cells. After 
4-day incubation in presence of AuNPs significant retardation of LNCaP cells growth was observed both in 5α-dihydrotestosterone 
stimulated and non-stimulated cultures. No morphological changes of live LNCaP cells were seen in any experiment. Conclusion: 
Given absence of morphological changes in live cells and dribble and relatively constant numbers of dead cells, it was concluded 
that inhibitory effect of AuNPs on LNCaP cells growth was caused by alterations of proliferation.
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Prostate adenocarcinoma (prostate cancer — PCa) 
is one of the most common cancer that affects 12–17% 
of male population in the developed countries [1, 2]. 
PCa case incidence and mortality increased during 
past decades. In the year of 2012, PCa in Ukraine was 
diagnosed as the second malignancy in human male 
population (after lung cancer) and the most common 
oncourological disease [3].
PCa represents a classical model of hormone-de-
pendent malignancy. In the most cases, growth of PCa 
is promoted by testosterone and other androgens. 
For this reason, advanced PCa is quite successfully 
treated by surgical or pharmacological (androgen 
receptor antagonists, hypothalamic luteinizing hor-
mone — releasing hormone analogues, estrogens and 
other drugs) androgen ablation. However, castration 
and hormonal therapy exert only palliative effect, and 
usually after remission the tumor relapses due to re-
fractoriness to drugs. Some patients initially demon-
strate refractoriness to castration or other modalities 
of systemic endocrine therapy. Possible mechanisms 
of hormone resistance include androgen receptor (AR) 
gene mutations and amplification, ligand-independent 
AR signaling, changed interplay between AR and 
growth factors, intratumoral conversion of adrenal 
androgens to testosterone, and so on. Alternative 
treatments are needed for aggressive localized PCa 
and hormone-refractory metastatic disease.
Modern nanotechnologies provide the new pos-
sibilities in biology and medicine [4, 5]. In the recent 
decades, nanotechnology has brought new hopes 
in malignant tumors diagnosis and targeted therapy. 
Among various nanoparticles, the gold ones (AuNPs) 
have received considerable appreciation by investiga-
tors and clinicians due to their unique properties [6–8]. 
They have inert core, permeate through the cell mem-
brane, can be functionalized easily, and demonstrate 
chemical stability and surface plasmon oscillation. 
Because of advanced technology of chemical syn-
thesis, a large range of AuNPs with different size, 
shape and optical properties are available. Currently, 
the AuNPs are already applied or likely to be applied 
in the foreseeable future for bio-nano-analytics, diag-
nostic, photothermal therapy and targeted drug de-
livery [9–13]. In the meantime, however, clinical trials 
of AuNPs as antitumor agents are rather limited, and 
much more basic research is still needed to facilitate 
their transition to clinical oncology.
Earlier we observed suppressive effect of AuNPs 
on human PCa xenograft growth in mouse model [14]. 
Exploration of their effects on PCa cells in vitro could 
bring new information on the peculiarities of interac-
tion between AuNPs and tumor cells. There was shown 
a cytotoxic influence of AuNPs on androgen-refractory 
PCa PC-3 cell line [15]. Cytotoxic activity of AuNPs 
conjugated with non-steroidal antiandrogens has been 
demonstrated in vitro toward hormone-insensitive 
PCa cell line [16]. Incorporation of AuNPs conjugated 
with glutamate carboxypeptidase inhibitor, prostate-
specific membrane antigen, into LNCaP and PC-3 cells 
was observed [17], but their effects on the cells 
have not been studied. In this article, we represent 
the results of exploration of the effects of simple, 
non-functionalized AuNPs on androgen-sensitive 
PCa LNCaP cells growing freely or stimulated with 
5α-dihydrotestosterone (DHT).
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MATERIALS AND METHODS
AuNPs. AuNPs were prepared using citric tech-
niques of reduction of chloroauric acid [18], and kindly 
provided to us by the Research Institute for Nano-
technological Industry, Open International University 
of Human Development “Ukraine”.
There was used ethanol dispersion of spherical 
AuNPs covered by polyvinylpyrrolidone (PVP) in order 
to prevent aggregation. The estimation of AuNPs pa-
rameters was carried out with laser correlation spec-
troscopy (Zetasizer-3, Malvern Instruments Ltd, UK).
Cells and experimental protocol. Human PCa 
cell line LNCaP was provided by R.E. Kavetsky Institute 
of Experimental Pathology, Oncology and Radiobio-
logy, National Academy of Sciences of Ukraine, Kyiv. 
Three series of experiments with similar design were 
carried out. Cells were cultured on 24 × 24 mm square 
glass cover slips placed in Petri dishes filled with 
culture medium of the following composition: RPMI-
1640 medium (Sigma), 10% fetal bovine serum 
(Sigma), 50.000 IU/l penicillin and 50 mg/l strepto-
mycin. Cell cultures were maintained in the thermostat 
at 37 °C in a 95% air — 5% CO2 humidified atmosphere. 
Culture medium was changed daily.
After cells’ density reached 50–60% of cover 
slip’s surface, the cultures were separated onto 
5 groups each consisting of 3–5 cover slips. The cul-
ture medium in the first group (control) contained 
ethanol, and the second one (PVP group) contained 
PVP-ethanol solution just to make sure it doesn’t af-
fect cells. The third group (AuNPs group) was exposed 
to AuNPs (10 μg/ml) alone, the fourth group (DHT 
group) contained DHT (10–4 M) alone, and the fifth 
group (AuNPs + DHT group) was supplemented with 
AuNPs (10 μg/ml) plus DHT (10–4 M). Ethanol con-
centration in culture medium of all experimental and 
control groups did not exceed 1%. After 4-days of cul-
turing with daily replacement of respective medium, 
cells from each group were detached from cover slips 
using 0.25% trypsin-EDTA in 0.5 ml medium, sus-
pended in additional 0.5 ml medium and centrifuged 
at 3200 rpm. The cells were resuspended in 1.0 ml me-
dium, stained with Trypan Blue in order to discriminate 
live and dead cells, and the numbers of live and dead 
cells were calculated in Goryaev chamber.
Morphological studies. Part of cover slips was 
used for morphological studies. The cells were fixed 
in 4% paraformaldehide, then stained with Ferrum 
hematoxylin and underwent examination using the mi-
croscope Leіka DME (Leika Microsystems, Germany).
Data analysis and statistics. Each experiment 
was repeated 4–6 times. Accretion percentage of cell 
counts in relation to initial seeding was calculated, 
and results were averaged and expressed as mean 
± s.e.m. (standard error of the mean). The results 
were compared with those of appropriate controls. 
Student’s t-test was used for statistical analysis, with 
p < 0.05 cons idered significant.
RESULTS AND DISCUSSION
AuNPs size measurements. It has been estima-
ted that the colloidal solution contained nanoparticles 
with sizes ranging from 15.3 to 30.9 nm (90% of total 
number) and the prevalence of 21.8 nm one (42% of to-
tal number) (Fig. 1). The average size of nanoparticles 
was estimated as 26.4 nm.
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Fig. 1. AuNPs size (diameter) and number distribution by laser 
correlation spectroscopy
LNCaP cells growth. During 4-day-growth period, 
a total count of control LNCaP cells (i.e., cultured 
in the presence of ethanol and/or PVP) increased 
7–21-fold. The relative numbers of dead cells against 
initial seeding increased only 2-fold, and was similar 
in all control and experimental groups. Given a total 
numbers of cultivated cells and numbers of live and 
dead cells in the end of the experiments, PVP in ap-
propriate amounts did not affect the culture growth 
versus the vehicle control (p > 0.05) (Fig. 2).
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Fig. 2. Effect of AuNPs on percentage of total counts of LNCaP 
cells after 4-day cultivation in RPMI 1640 medium in relation 
to initial seeding (M ± m). Footnotes: Each bar represents 
an average data from 3 experiments. *р < 0.05 in comparison 
with ethanol control
Our preliminary in vitro experiments with various 
AuNPs concentrations of 0.1; 1.0 and 10.0 μg/ml had 
shown that only 10.0 μg/ml of AuNPs was effective 
in affecting LNCaP cells growth. In this study, after 
4-day incubation of LNCaP cells in presence of AuNPs 
(10.0 μg/ml) we observed significant suppression 
of cells’ growth. AuNPs decreased the total cells 
count on average by 40% and live cells count by 43% 
compared to the control, and both decreases were 
statistically significant (p < 0.02).
Supplementing culture medium with DHT stimulated 
LNCaP cells growth by increasing total cells count 
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on average by 57% and live cells count by 61% compared 
to the control. Addition of AuNPs in the presence of DHT 
dramatically reduced stimulatory effect of DHT on LNCaP 
cells growth by 80% and 77% when counted by the ac-
cretion of total and live cells, respectively, and brought 
total cell counts to control level (p > 0.05).
Cell morphology. Dark violet increments, suppo-
sedly aggregates of nanoparticles, were clearly seen 
in cells cultivated with AuNPs. No morphological changes 
of live LNCaP cells were seen in any experiment (Fig. 3).
In summary, it must be emphasized that we used 
androgen-sensitive LNCaP cell line derived from 
the human PCa lymph node metastasis to study the ef-
fects of non-functionalized AuNPs on cells’ growth.
There is some discrepancy in published works con-
cerning cytotoxicity of AuNPs toward eukaryotic cells. 
Cytotoxicity has been reported by a few authors [19, 
20], meanwhile others did not observe it [21]. Cytoto-
xity of AuNPs both in vitro and in vivo strongly depends 
on particles’ size, shape, dose, surface composition 
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Fig. 3. Appearance of DHT stimulated and non-stimulated LNCaP 
cell cultures after 4 days growing with AuNPs (a — 96% ethanol; 
b — PVP ethanol solution; c — AuNPs (10 μg/ml), visualization 
of the nanoparticle aggregates; d — DHT (10–4 M); increased 
mitotic activity; e — AuNPs (10 μg/ml) and DHT (10–4 M), visu-
alization of the nanoparticle aggregates). Ferrum hematoxylin, 
× 300. Entire arrows indicate mitosis, dot arrows indicate apoptosis
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and other features [15, 22–24]. Similarly to other 
metallic nanoparticles, AuNPs interact with cellular 
membrane, mitochondria, nucleus, resulting in dama-
ging DNA and organelles, oxidative stress, apoptosis.
In this study, we explored relatively homogenous 
population of spherical AuNPs with average size 
of about 26 nm. By being added to the culture medium 
at concentration 10.0 μg/ml, these AuNPs inhibited 
non-stimulated LNCaP cell line growth significantly. The 
ratios of dead cells in the control and AuNPs-treated 
cultures relative to the initially seeded cells were minor 
and remained quite constant, whereas the relative num-
bers of live cells in the presence of AuNPs decreased 
dramatically. Suppression of cell growth by AuNPs 
in DHT stimulated culture was quite noticeable. Taken 
into consideration that DHT binds to nuclear AR, which 
interacts with specific regions of DNA followed by ex-
pression of growth factors and stimulation of mitosis, 
it can be assumed that AuNPs interfere with androgen 
and/or growth factor signaling in the affected cancerous 
cells. Morphology of live cells did not change, and num-
bers of visualized apoptotic cells were similar in control 
and experimental groups. From these observations, 
we have concluded, that AuNPs suppressed cell prolif-
eration rather than caused apoptosis or necrosis.
AuNPs conglomerates have been visualized 
in cultured cells, which is in line with reported data 
on the ability of nanoparticles with 30 nm diameter 
or less to be endocytosed by cells [15, 20, 25, 26]. 
It was shown in human histiocyte-rich lymphoma 
U937 cell line that 20–30 nm AuNPs have a greater cell 
accumulation than that of nanoparticles of other size 
with prevalent localization in the lysosomes [11, 20]. 
3–5 nm AuNPs penetrate nucleus easily. AuNPs capa-
city to damage DNA deserves special attention in terms 
of their safety. It was shown that even 10–20 nm AuNPs 
can damage DNA structure in СНО-К1 cell line, 
meanwhile 30 nm and 45 nm AuNPs were safe [27]. 
Genotoxity might be a cause of suppressive influence 
of AuNPs on LNCaP cell growth in our experiments.
One possible mechanism of AuNPs induced inhibi-
tion of LNCaP cell growth is modulation of the cell mem-
brane enzyme activity. Though gold per se is known 
to be inert metal, AuNPs possess high catalytic proper-
ties [5]. For instance, it had been reported their ability 
to modulate in vitro the U937 tumor cell membrane Na+, 
K+-ATPase activity [20]. Since Na+, K+ -ATPase acti vity 
is required for adequate regulation of cell volume, 
which undergoes significant disturbances during cell-
cycle progression, one might suggest that impaired 
cell volume regulation may in part be responsible 
for the anti-proliferative action of AuNPs. However, 
biochemical mechanisms underlying effect of AuNPs 
on cancerous cells are still poorly investigated and 
understood.
There is a hope that in the future AuNPs could earn 
a place in the treatment of PCa, however, much work 
for this is to be addressed.
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